中文
English
About Us
Company
Team
Honor
Vision & Mission
Contact Us
Pipeline
Innovation
Biosimilar
R & D
Antibody Screening
Pharmacodynamics
Protein/Ab Engineering
Process Dev
Multi-functional Fc platform
While the specificity of mAbs are fully appreciated, at the early days, scien...
In vitro/In vivo Pharmaco...
In vitro/In vivo Pharmacology Evaluation Platform in Alphamab including cell b...
Manufacturing
Pilot Production
Quality System
Partnering
Opportunities
Corporation
Academic
News
Press Release
Worth to be Noted
Career
Career opportunity
Apply On-line
News
Press Release
Worth to be Noted
---- Useful Link ----
Alphamab Jilin
DingFu Biotarget
Shihuida Pharma
CFDA
CDE
NIFDC
Press Release
Home
>
News
>
Press Release
KN035 (Envafolimab) Phase IIb HBV Clinical Trial initiated
Learn More
Press Release
Events
Date
徐霆博士在China Bio上接受Bioworld的采访
2014-07-31
转让给正大天晴的重组人凝血八因子完成IND申报
2014-06-30
康宁杰瑞通过ChinaBio会议,与国际知名制药公司开始接触
2014-05-30
公司组织桂林旅游,庆祝KN015临床申报工作完成
2014-04-25
康宁杰瑞股权激励项目正式启动
2014-04-18
total7Record,total2Page,Current1Page
Home Page
Pre
Next
End
Home
|
About Us
|
Pipeline
|
R & D
|
Manufacturing
|
Partnering
|
News
|
Career